Deciphera Pharmaceuticals LLC (NASDAQ:DCPH) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Ron Squarer Other companies: Nuvalent, Inc. (Director · Since at least Dec 10, 2025); ADC Therapeutics SA (Director · Since at least Jan 2, 2024); Travere Therapeutics, Inc. (Director · Since at least May 14, 2021) | Director · Jan 15, 2021 – Jun 11, 2024 · Past |
| James Bristol Other companies: Erasca, Inc. (Director · Since at least Jan 1, 2024); Ernexa Therapeutics Inc. (Chairman · Since at least Oct 30, 2023) | Director · Jun 11, 2024 – Jun 11, 2024 · Past |
| Dashyant Dhanak Other companies: Incyte Corporation (EVP & Chief Scientific Officer · Dec 10, 2018 – Jul 14, 2023 · Past) | EVP & Chief Scientific Officer · Sep 5, 2023 – Jun 11, 2024 · Past |
| Edward J Benz Jr Other companies: Candel Therapeutics, Inc. (Director · Since at least Jun 26, 2024) | Director · Jun 11, 2024 – Jun 11, 2024 · Past |
| Matthew L Sherman Other companies: Palvella Therapeutics, Inc. (Director · Jun 25, 2021 – Jun 21, 2023 · Past) | EVP & Chief Medical Officer · Oct 2, 2020 – Jun 11, 2024 · Past |
| Thomas Patrick Kelly Other companies: Xenon Pharmaceuticals Inc. (Chief Financial Officer · Since at least Oct 15, 2025) | Chief Financial Officer · May 1, 2019 – Jun 11, 2024 · Past |
| Daniel C Martin | Chief Commercial Officer · Sep 18, 2018 – Jun 11, 2024 · Past |
| Daniel Lee Flynn | Chief Scientific Officer · Sep 27, 2017 – Jun 16, 2023 · Past |
| Dennis Leo Walsh | Director · Sep 27, 2017 – Jun 11, 2024 · Past |
| Franklin Stuart Friedman | Director · Nov 25, 2019 – Jun 11, 2024 · Past |
| Oliver Rosen | Chief Medical Officer · Sep 27, 2017 – Oct 2, 2017 · Past |
| Stephen B Ruddy | Chief Technical Officer · May 29, 2018 – Jan 30, 2019 · Past |